Accessibility Menu
Intelicare logo

Intelicare(ASX) ICR

Market CapA$18.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-91%
5 Year-77%
1 Year+53%
1 Month+13%
A$0.03
+0.00%
+0.00Today
Intelicare last closing stock price
MetricPriceDate
Last closeAUD 0.032026-09-07
Intelicare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.14%AUD 0.032026-08-31
1 month+13.04%AUD 0.022026-08-07
3 month+13.04%AUD 0.022026-06-09
Year to date+8.33%AUD 0.022025-12-31
1 year+52.94%AUD 0.022025-09-05
3 year+100%AUD 0.012023-09-06
5 year-77.39%AUD 0.122021-09-08
Since inception-90.54%AUD 0.272020-05-25

Intelicare Financials at a Glance

Market Cap

A$18.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$3.00M

Net Income (TTM)

-A$4.34M

EPS (TTM)

-A$0.00

P/E Ratio

-7.65

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$0.03

Volume

0

Open

A$0.03

Previous Close

A$0.03

Daily Range

A$0.03 - A$0.03

52-Week Range

A$0.01 - A$0.04

Estimated Earnings Date

Mar 4, 2027

ICR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intelicare

Intelicare Holdings Limited is an innovative company based in Leederville, Australia, focused on providing predictive analytics solutions for the aged care and health industries. Founded in 2016, the company combines hardware and software to enhance the quality of care for seniors and individuals with disabilities.

Products and Services
  • InteliLiving: A solution designed to assist seniors and individuals with disabilities
  • Specialized monitoring systems for elderly and vulnerable populations
  • Predictive analytics solutions tailored for the healthcare sector
Growth Outlook
  • Increasing demand for aged care solutions in Australia supports market expansion
  • Strategic partnerships may enhance product offerings and market reach
  • Focus on innovation positions the company for future growth opportunities
Financial Highlights
  • Recent quarterly revenue of AUD 489,707 shows potential for growth
  • Trailing twelve months (TTM) net income margin of -8.06% indicates room for improvement
  • Current ratio of 0.85 suggests manageable short-term liabilities
Intelicare Holdings Limited operates in a niche market with significant growth potential, driven by the increasing need for effective aged care solutions. The company's innovative products, such as InteliLiving, are designed to meet the unique needs of seniors and individuals with disabilities, positioning it well within the healthcare sector. Recent financial data indicates a revenue increase, although challenges remain in achieving profitability. The company's focus on strategic partnerships and innovation may provide avenues for future growth, making it an intriguing option for investors interested in the healthcare information services industry.
AI Generated • Aug 19, 2026

Industry

Health Care Technology

CEO

Angus Cameron

Headquarters

Leederville, WA 6007, AU

ICR Financials

Key Financial Metrics (TTM)

Gross Margin

-637.73%

Operating Margin

-1108.70%

Net Income Margin

-806.06%

Return on Equity

-578.72%

Return on Capital

-145.59%

Return on Assets

-148.95%

Earnings Yield

-13.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$18.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

715.31M

Volume

0

Avg. Volume

427.79K

Financials (TTM)

Gross Profit

-A$2.21M

Operating Income

-A$5.26M

EBITDA

-A$4.54M

Operating Cash Flow

-A$2.85M

Capital Expenditure

-A$10.91K

Free Cash Flow

-A$2.86M

Cash & ST Invst.

A$2.73M

Total Debt

A$524.82K

Intelicare Performance Analysis

Intelicare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 404,345-5.9%
20242024-06-30AUD 280,292-30.7%
20252025-06-30AUD 956,740241.3%
20262026-06-30AUD 2,041,828113.4%
Intelicare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31217.8%
Q42025-06-30-9.0%
Q22025-12-317.5%
Q42026-06-30216.9%
Intelicare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.02-47.2%
20242024-06-30AUD -0.01-44.4%
20252025-06-30AUD -0.00-51.0%
20262026-06-30AUD -0.00-30.6%
Intelicare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3151.4%
Q42025-06-3011.8%
Q22025-12-3120.0%
Q42026-06-3058.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$1.55M

+884.6%

Gross Profit

-A$476.94K

+48.3%

Gross Margin

-30.73%

N/A

Market Cap

A$18.60MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$2.32M

N/A

Employees

8

N/A

Net Income

-A$729.88K

+54.3%

EBITDA

-A$1.23M

+19.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$2.73M

+227.0%

Total Debt

A$524.82K

-14.3%

Accounts Receivable

A$290.78K

+40.9%

Inventory

A$147.55K

-49.9%

Long Term Debt

A$0.00

N/A

Short Term Debt

A$524.82K

-14.3%

Return on Assets

-1.49%

N/A

Return on Invested Capital

18.46%

N/A

Free Cash Flow

A$354.47K

+129.9%

Operating Cash Flow

A$355.83K

+130.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VBS.AXVectus Biosystems Limited
A$0.17+0.00%
IXC.AXInvex Therapeutics Ltd
A$0.12+0.00%
HIQ.AXHITIQ Limited
A$0.01+20.00%
BGT.AXBio-Gene Technology Limited
A$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About ICR

What is the current price of Intelicare?

Intelicare is trading at A$0.03 per share.

What is the 52-week range for Intelicare?

Over the past 52 weeks, Intelicare has traded between A$0.01 and A$0.04.

How much debt does Intelicare have?

As of the most recent reporting period, Intelicare reported total debt of A$524.82K.

How much cash does Intelicare have on hand?

Intelicare reported A$2.73M in cash and cash equivalents in its most recent financial results.

What is Intelicare’s dividend yield?

Intelicare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.